Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2010-10-28
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 25
- Registration Number
- NCT01012908
- Locations
- 🇧🇷
Lal Clinica Pesquisa E Desenvolvimento Ltda, Valinhos, SP, Brazil
Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2009-07-08
- Last Posted Date
- 2010-10-27
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 140
- Registration Number
- NCT00934167
- Locations
- 🇧🇷
Lal Clinica Pesquisa E Desenvolvimento Ltda, Valinhos, SP, Brazil
Comparison of Two Heparin Formulations in Patients With Chronic Renal Failure.
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2009-06-05
- Last Posted Date
- 2010-10-27
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 120
- Registration Number
- NCT00914472
- Locations
- 🇧🇷
Lal Clinica Pesquisa E Desenvolvimento Ltda, Valinhos, SP, Brazil
Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients
Phase 3
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- Azidus Brasil
- Registration Number
- NCT00912483
Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2011-01-28
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 104
- Registration Number
- NCT00905216
- Locations
- 🇧🇷
Lal Clinica Pesquisa E Desenvolvimento Ltda, Valinhos, SP, Brazil
Efficacy and Safety of Sodium Heparin (Hipolabor) in Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 104
- Registration Number
- NCT00894673
- Locations
- 🇧🇷
Lal Clinica Pesquisa e Desenvolvimento Ltda, Valinhos, SP, Brazil
🇧🇷LAL Clinica, Valinhos, SP, Brazil
Efficacy and Safety of Sodium Heparin (Eurofarma)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 104
- Registration Number
- NCT00894829
- Locations
- 🇧🇷
LAL Clinica Pesquisa e Desenvolvimento Ltda, Valinhos, Sao Paulo, Brazil
Efficacy and Safety of Sodium Heparin
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 104
- Registration Number
- NCT00894985
- Locations
- 🇧🇷
Lal Clinica Pesquisa E Desenvolvimento Ltda, Valinhos, SP, Brazil
Efficacy and Safety of Sodium Heparin in Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 104
- Registration Number
- NCT00894959
- Locations
- 🇧🇷
LAL clinica pesquisa e desenvolvimento ltda, Valinhos, SP, Brazil
Efficacy and Safety of Sodium Heparin in Patients (Cristália)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 104
- Registration Number
- NCT00894998
- Locations
- 🇧🇷
LAL Clinica Pesquisa e Desenvolvimento Ltda, Valinhos, São Paulo, Brazil
© Copyright 2024. All Rights Reserved by MedPath